Bosh sahifaAUROPHARMA • NSE
add
Aurobindo Pharma Ltd
Yopilish kursi
1 227,45 ₹
Kunlik diapazon
1 218,10 ₹ - 1 236,55 ₹
Yillik diapazon
958,50 ₹ - 1 592,00 ₹
Bozor kapitalizatsiyasi
718,16 mlrd INR
Oʻrtacha hajm
895,22 ming
Narx/foyda
19,97
Dividend daromadliligi
-
Asosiy maydon
NSE
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (INR) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | 77,96 mlrd | 7,99% |
Joriy xarajat | 34,02 mlrd | 13,51% |
Sof foyda | 8,17 mlrd | 7,95% |
Sof foyda marjasi | 10,48 | -0,10% |
Har bir ulushga tushum | 14,00 | 9,12% |
EBITDA | 15,77 mlrd | 16,15% |
Amaldagi soliq stavkasi | 32,34% | — |
Balans
Jami aktivlari
Jami passivlari
| (INR) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 68,68 mlrd | -3,93% |
Jami aktivlari | 480,94 mlrd | 9,50% |
Jami passivlari | 172,09 mlrd | 9,41% |
Umumiy kapital | 308,85 mlrd | — |
Tarqatilgan aksiyalar | 583,84 mln | — |
Narxi/balansdagi bahosi | 2,32 | — |
Aktivlardan daromad | — | — |
Kapitaldan daromad | 7,81% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (INR) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 8,17 mlrd | 7,95% |
Operatsiyalardan naqd pul | — | — |
Sarmoyadan naqd pul | — | — |
Moliyadan naqd pul | — | — |
Naqd pulning sof oʻzgarishi | — | — |
Boʻsh pul | — | — |
Haqida
Aurobindo Pharma Limited is an Indian multinational pharmaceutical manufacturing company headquartered in HITEC City, Hyderabad. The company manufactures generic pharmaceuticals and active pharmaceutical ingredients. The company's area of activity includes six major therapeutic and product areas: antibiotics, anti-retrovirals, cardiovascular products, central nervous system products, gastroenterologicals, and anti-allergics. The company markets these products in over 125 countries. Its marketing partners include AstraZeneca and Pfizer. Wikipedia
Tashkil etilgan
1986
Bosh ofis
Sayt
Xodimlar soni
26 015
